SCHEMBL23959772

SCHEMBL23959772

Cc1ccc(-c2nc3cccc4c(=O)ccn2c34)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 10/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
LMNA P02545 2/20 0.45
PARP1 P09874 2/20 0.45
GAA P10253 1/20 0.45
KDM4E B2RXH2 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 2/20 0.42
MDM2 Q00987 1/20 0.42
GLA P06280 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
PTGS2 P35354 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
TNKS O95271 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959794 0.87 SMN1; SMN2 (0.44) TSHRSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL23959788 0.75 KDM4E (0.53) TSHRSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL23959779 0.75 ALDH1A1 (0.52) ALDH1A1MEN1KMT2ALMNAPARP1
SCHEMBL23959843 0.71 ATM (0.42) TSHRALDH1A1LMNAGAAKDM4E
SCHEMBL23959783 0.69 CYP1A2 (0.44) TSHRSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL8503249 0.68 TSHR (0.65) TSHRSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL30311730 0.68 TSHR (0.65) TSHRSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL20102622 0.67 KMT2A (0.82) TSHRSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL7770196 0.66 ALDH1A1 (0.86) SMN1; SMN2ALDH1A1MEN1KMT2ALMNA
SCHEMBL6314431 0.63 MEN1 (0.67) ALDH1A1MEN1KMT2AGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210332038-A1 6H-IMIDAZO[4,5,1-ij]QUINOLONE, SYNTHESIS METHOD AND USE THEREOF HANGZHOU NORMAL UNIVERSITY 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332038-A1 6H-IMIDAZO[4,5,1-ij]QUINOLONE, SYNTHESIS METHOD AND USE THEREOF ABL1, KCNK4, KCNJ4 TSHR 2316/4885SMN1; SMN2 4559/4885ALDH1A1 1428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.